title: Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: a randomized multicenter trial by the EBMT Chronic Leukemia Working Party.
authors.forename: S
authors.initials: S
authors.lastname: Knop
authors.forename: H
authors.initials: H
authors.lastname: Hebart
authors.forename: A
authors.initials: A
authors.lastname: Gratwohl
authors.forename: C
authors.initials: C
authors.lastname: Kliem
authors.forename: C
authors.initials: C
authors.lastname: Faul
authors.forename: E
authors.initials: E
authors.lastname: Holler
authors.forename: J
authors.initials: J
authors.lastname: Apperley
authors.forename: H J
authors.initials: HJ
authors.lastname: Kolb
authors.forename: A
authors.initials: A
authors.lastname: Schaefer
authors.forename: D
authors.initials: D
authors.lastname: Niederwieser
authors.forename: H
authors.initials: H
authors.lastname: Einsele
mesh_terms: D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000276:immunology / Q000382:microbiology / Q000628:therapy; D016026:Bone Marrow Transplantation; D017252:CD3 Complex / Q000032:analysis; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D006086:Graft vs Host Disease / Q000382:microbiology / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D007938:Leukemia / Q000150:complications / Q000628:therapy; D008223:Lymphoma / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D036102:Peripheral Blood Stem Cell Transplantation; D011446:Prospective Studies; D012074:Remission Induction; D013256:Steroids / Q000627:therapeutic use*
chemical_list: D017252:CD3 Complex; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D013256:Steroids